Incidence and Transmission Dynamics of Bordetella pertussis Infection in Rural and Urban Communities, South Africa, 2016‒2018.
Bordetella pertussis
South Africa
bacteria
cohort study
colonization
household transmission
incidence
incidence and transmission dynamics
infection
pertussis
respiratory infections
rural and urban communities
whooping cough
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
entrez:
24
1
2023
pubmed:
25
1
2023
medline:
27
1
2023
Statut:
ppublish
Résumé
We conducted 3 prospective cohort studies (2016-2018), enrolling persons from 2 communities in South Africa. Nasopharyngeal swab specimens were collected twice a week from participants. Factors associated with Bordetella pertussis incidence, episode duration, and household transmission were determined by using Poisson regression, Weibull accelerated time-failure, and logistic regression hierarchical models, respectively. Among 1,684 participants, 118 episodes of infection were detected in 107 participants (incidence 0.21, 95% CI 0.17-0.25 infections/100 person-weeks). Children <5 years of age who had incomplete vaccination were more likely to have pertussis infection. Episode duration was longer for participants who had higher bacterial loads. Transmission was more likely to occur from male index case-patients and persons who had >7 days infection duration. In both communities, there was high incidence of B. pertussis infection and most cases were colonized.
Identifiants
pubmed: 36692337
doi: 10.3201/eid2902.221125
pmc: PMC9881781
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
294-303Subventions
Organisme : Wellcome Trust
ID : 058893/Z/99/A
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 069683/Z/02/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 085477/Z/08/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 085477/B/08/Z
Pays : United Kingdom
Organisme : NCIRD CDC HHS
ID : U51 IP000155
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW011255
Pays : United States
Références
Euro Surveill. 2016 Nov 10;21(45):
pubmed: 27918260
Clin Infect Dis. 2012 Jun;54(12):1730-5
pubmed: 22423127
Lancet Glob Health. 2021 Jun;9(6):e863-e874
pubmed: 34019838
Clin Infect Dis. 2020 Jul 11;71(2):403-411
pubmed: 31562530
Commun Dis Intell Q Rep. 2015 Mar 31;39(1):E27-33
pubmed: 26063095
BMJ. 2013 Jul 17;347:f4249
pubmed: 23873919
BMC Med. 2015 Jun 24;13:146
pubmed: 26103968
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):787-92
pubmed: 24277828
Clin Vaccine Immunol. 2010 Dec;17(12):2016-23
pubmed: 20926698
PLoS One. 2020 Oct 15;15(10):e0240717
pubmed: 33057415
Pediatr Infect Dis J. 2016 Jun;35(6):611-6
pubmed: 26967813
Diagn Microbiol Infect Dis. 2012 Apr;72(4):303-17
pubmed: 22313629
Clin Infect Dis. 2016 Dec 1;63(suppl 4):S165-S173
pubmed: 27838669
BMC Infect Dis. 2019 Mar 21;19(1):276
pubmed: 30898099
Influenza Other Respir Viruses. 2021 Nov;15(6):789-803
pubmed: 34296810
BMC Public Health. 2011 Sep 07;11:694
pubmed: 21899765
Clin Infect Dis. 2021 Aug 2;73(3):e745-e753
pubmed: 33530100